skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Sculpting a Uniquely Reactive Cysteine Residue for Site-Specific Antibody Conjugation

Journal Article · · Bioconjugate Chem.

Research Organization:
Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Organization:
DOE - Office Of Science; National Institutes of Health (NIH)
OSTI ID:
1877208
Journal Information:
Bioconjugate Chem., Vol. 33, Issue (6)
Country of Publication:
United States
Language:
ENGLISH

References (21)

An Insight into FDA Approved Antibody-Drug Conjugates for Cancer Therapy journal September 2021
Strategies and challenges for the next generation of antibody–drug conjugates journal March 2017
Selective chemical protein modification journal September 2014
Characterization and Higher-Order Structure Assessment of an Interchain Cysteine-Based ADC: Impact of Drug Loading and Distribution on the Mechanism of Aggregation journal February 2016
Antibody–Drug Conjugates (ADCs) Derived from Interchain Cysteine Cross-Linking Demonstrate Improved Homogeneity and Other Pharmacological Properties over Conventional Heterogeneous ADCs journal October 2015
Understanding How the Stability of the Thiol-Maleimide Linkage Impacts the Pharmacokinetics of Lysine-Linked Antibody–Maytansinoid Conjugates journal June 2016
Self-hydrolyzing maleimides improve the stability and pharmacological properties of antibody-drug conjugates journal September 2014
A Humanized Aldolase Antibody for Selective Chemotherapy and Adaptor Immunotherapy journal September 2003
Direct Observation of an Enamine Intermediate in Amine Catalysis journal December 2009
Chemically programmed monoclonal antibodies for cancer therapy: Adaptor immunotherapy based on a covalent antibody catalyst journal April 2003
β-Lactam-based approach for the chemical programming of aldolase antibody 38C2 journal March 2009
Site-Specific Lysine Arylation as an Alternative Bioconjugation Strategy for Chemically Programmed Antibodies and Antibody–Drug Conjugates journal November 2019
Harnessing a catalytic lysine residue for the one-step preparation of homogeneous antibody-drug conjugates journal October 2017
Site-Selective Antibody Functionalization via Orthogonally Reactive Arginine and Lysine Residues journal September 2019
An Engineered Arginine Residue of Unusual pH-Sensitive Reactivity Facilitates Site-Selective Antibody Conjugation journal March 2021
Protein Modification, Bioconjugation, and Disulfide Bridging Using Bromomaleimides journal January 2010
Rapid, Stable, Chemoselective Labeling of Thiols with Julia-Kocieński-like Reagents: A Serum-Stable Alternative to Maleimide-Based Protein Conjugation journal October 2013
Stable and Potent Selenomab-Drug Conjugates journal April 2017
Site-Specific Antibody–Drug Conjugates in Triple Variable Domain Fab Format journal May 2020
Dual-mechanistic antibody-drug conjugate via site-specific selenocysteine/cysteine conjugation journal October 2019
Antibody-drug conjugates with dual payloads for combating breast tumor heterogeneity and drug resistance journal June 2021